Beta-Blocker-Induced Psoriasis: A Rare Side Effect

Abstract

Beta blockers are one of the oral agents shown to decrease cardiovascular morbidity and mortality rates in randomized, controlled trials, and hence, they are widely used for the management of many cardiovascular situations. In terms of side effects there are 3 major modes of action: (1) contraction of smooth muscles, particularly of bronchi with nonselective agents; (2) exaggerated cardiac effects; and (3) central nervous system effects. There are also some rare side effects of beta blockers, some of which are unpredictable, but the others are related to mode of action at the cellular level. Beta-blocking agents may cause psoriaform eruptions and worsen existing psoriasis. Psoriasis may be an inconvenient side effect of beta blockade. Herein, we report a case of beta-blocker-induced psoriasis.

Get full access to this article

View all access options for this article.

References

Frishman WH , Sonnenblick EH : Beta-adrenergic blocking drugs and calcium channel blockers. In: Hurst's The Heart, ed 9, ed. by Alexander RW , Schlant RC , Fuster V. New York: McGraw-Hill , 1998, pp 1583-1618.

Opie LH , Sonnenblick EH , Frishman WH , et al: Beta-blocking agents. In: Drugs for the Heart, ed. 4, ed. by Opie LH. Philadelphia: WB Saunders Company, 1995, pp 1-29.

Ridley CM : Skin reactions to practolol. Br Med J 229:719, 1974.

Hu CH , Miller AC , Peppercorn R. , et al: Generalized pustular psoriasis provoked by propranolol. Arch Dermatol 121:1326-1327, 1985 .

Hadden JW , Hadden EM , Middleton E. : Lymphocyte blast transformation. Demonstrations of adrenergic receptors in human peripheral lymphocytes. Cell Immunol 1:583-595, 1970.

Gold MH , Holy AK , Roenigk HH : Beta-blocking drugs and psoriasis. J Am Acad Dermatol 19:837-841, 1988.